A Phase 1, Randomized, Open-Label, 2-part Study to Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor in Combination With Tezacaftor and Deutivacaftor in Healthy Adult Subjects
Latest Information Update: 05 Jul 2024
At a glance
- Drugs Deutivacaftor/tezacaftor/vanzacaftor (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
Most Recent Events
- 24 Jun 2024 Status changed from active, no longer recruiting to completed.
- 03 Jun 2024 Status changed from recruiting to active, no longer recruiting.
- 29 Mar 2024 Status changed from not yet recruiting to recruiting.